# P11 Bio — Accountable Technical Review

Node: `P11`  
Issue: #29  
Base integration commit: `4d2186da8b2958c7618a233f53908f2914c389a3`  
Authority: `GJ-V10-MP-GREENFIELD-2026-08-20`, `GJ-V10-IA-GREENFIELD-2026-08-20`, `GJ-V10-DS-GREENFIELD-2026-08-20`  
Status: **APPROVED — TECHNICAL REVIEW SIGNED / SAME-REVISION CI REQUIRED**

## 1. Review boundary

This document records the accountable P11 technical review after the frozen contract, implementation, real integration/browser evidence, exact-head coherence, and pre-sign closure completed successfully. The signature approves the P11-owned implementation and evidence identified below; it does not, by itself, make this signed revision merge-authoritative. The signed revision itself must rerun and pass the complete affected exact-head matrix and P11-T001..P11-T020 closure before P11 can be marked complete or merged.

Legacy Bio code, manually edited database rows, fixture-only child-risk states, mocked browser requests, screenshot-only proof, a clickable blocked destination, robots metadata without raw HTTP verification, or a sitemap assertion without inspectable diff cannot substitute for current-repository P11 evidence.

P11 closes only CAP-BIO and its own Bio UGC/noindex contribution when same-revision signed closure passes. `CAP-BIO-OPT-IN-INDEX` remains DEFERRED. P16 destination-risk review/admin lifecycle and release-wide G7 remain later-owned; release-wide G7 remains later-owned by P18/P19/P20/P22.

## 2. Frozen capability and ownership boundary

- `CAP-BIO` — REQUIRED — owner P11 — Gates G3/G7.
- Master Plan P11 Entry: public resource and Design System patterns available; dependency ledger names P05.
- Integrated base is `main` at `4d2186da8b2958c7618a233f53908f2914c389a3`, containing the merged P10 implementation.
- P11 may close CAP-BIO and its own Bio UGC/noindex contribution only.
- `CAP-BIO-OPT-IN-INDEX` is **DEFERRED**: P11 must not expose an indexing toggle, field, persisted authority or public opt-in path.
- P11 consumes current-repository destination-risk safety authority for child links but does not claim the later P16 review/admin lifecycle complete.
- Release-wide G7 remains later-owned by P18/P19/P20/P22.

Inherited predecessor signed authority is P10 source `7db4fca49ba3fd8e60600ecdf41847c7e2f94776`, closure run `32643830718`, artifact `9494371271`, digest `sha256:6a4bcaed870c6432df40e1fe71cb38dd05a84789d3539ab10dabcbfefe450c50`, `phase=signed`, `merge_authoritative=true`, defects P0=0/P1=0/`DECISION REQUIRED`=0.

## 3. Frozen route and API authority

IA-authoritative routes/dependencies:

```text
APP-BIO         /app/bio
APP-BIO-DETAIL  /app/bio/{pageId}
PUB-BIO         /p/{slug}
PUB-BIO API     GET /api/public/bio/{slug}
```

For Workspace Bio, the IA names required Bio APIs and route-using Bio APIs; it does **not** freeze an exact Workspace HTTP method/path family. P11 therefore freezes the following **current-repository implementation contract**, which must never be described as IA-exact authority:

```text
GET    /api/workspaces/{id}/bio-pages
POST   /api/workspaces/{id}/bio-pages
GET    /api/workspaces/{id}/bio-pages/{pageId}
PATCH  /api/workspaces/{id}/bio-pages/{pageId}
DELETE /api/workspaces/{id}/bio-pages/{pageId}
POST   /api/workspaces/{id}/bio-pages/{pageId}/publish
POST   /api/workspaces/{id}/bio-pages/{pageId}/pause
```

Child links are managed as server-authoritative ordered page data. No extra legacy route family or compatibility alias is approved.

## 4. Frozen Bio and child-link authority

1. Bio pages are Workspace-owned and every internal read/mutation/publish/pause action repeats server-side authentication, tenant and RBAC checks.
2. Public path authority is an opaque server-generated slug; internal page IDs are not public path authority.
3. Title, profile text and child labels are UTF-8 data and must not execute as active markup/script.
4. Only normalized `http`/`https` destinations are eligible child links; malformed, executable, credential-bearing or unsupported targets are rejected server-side.
5. Every child destination is bound to a normalized fingerprint and current-repository destination-risk result.
6. Changing a destination invalidates its previous allow authority; a stale allow result cannot authorize the new target.
7. `review` or `blocked` children must not remain active public navigation targets. A published Bio page may remain available while those children are rendered as non-navigable safety states.
8. P11 does not claim P16 completion of provider review, operator adjudication or broader destination-risk admin workflows.
9. Draft Bio pages are not public and return 404. Published active pages return 200. Paused pages use the explicit IA paused public state, return 200 noindex, and expose no active child navigation. Removed pages return 410.
10. Versioned mutation uses optimistic concurrency; stale writes return 409.
11. Removed pages cannot be resurrected by stale writes.
12. Public API output mirrors publication/removal and child-link safety authority and must not expose Workspace IDs, provider evidence, internal risk reasons or secrets.

## 5. Frozen public UGC / G7 subset

`PUB-BIO /p/{slug}` is permanently `noindex` in GoJet V10 P11.

- Sitemap membership: **no**.
- Canonical: none.
- Locale alternate/hreflang: none.
- Structured data: none.
- Metadata source: resource-safe title only.
- Internal-link parent: Workspace publish action only.
- Published active: 200.
- Paused: 200 explicit noindex state with no active child navigation.
- Unknown/unpublished/draft: 404.
- Removed: 410.
- HTML must expose noindex semantics.
- Public/API machine responses carry applicable `X-Robots-Tag: noindex, nofollow`.
- Every rendered outbound navigation link must include `rel="ugc nofollow"`.
- Review/blocked child destinations cannot appear as active href/navigation targets.
- Public Bio UGC must not enter Website or Docs sitemaps.
- `CAP-BIO-OPT-IN-INDEX` remains DEFERRED; no owner opt-in indexing behavior is permitted.

This is a P11 G7 Bio UGC/noindex contribution, not release-wide G7 closure.

## 6. Workspace state contract

`APP-BIO /app/bio` applicable IA states:

`loading`, `empty`, `edit`, `preview`, `publish-error`, `quota-reached`.

`APP-BIO-DETAIL /app/bio/{pageId}` applicable IA states:

`loading`, `draft`, `preview`, `published`, `child-link-review`, `child-link-block`, `conflict`, `deleted`.

`PUB-BIO /p/{slug}` applicable IA states:

`available`, `paused`, `risk-blocked-child-link`, `removed`, `not-found`.

The implementation may compose only existing Design System tokens/components. Exact visual values remain owned exclusively by the Design System.

## 7. Evidence and case contract

Required P11 case range: **P11-T001..P11-T020**.

The `P11-Txxx` identifiers are frozen by this P11 contract revision. The Master Plan supplies the requirements—not these IDs—including ownership, risk-blocked link, mobile, noindex and sitemap exclusion evidence.

Evidence root: `artifacts/v10/P11/`.

Required specialized evidence:

- `artifacts/v10/P11/api/`
- `artifacts/v10/P11/browser/`
- `artifacts/v10/P11/headers/`
- `artifacts/v10/P11/sitemap/` with inspectable sitemap diff
- exact-head evidence index / producer bindings
- signed affected-regression closure

P11 implementation evidence covers Backend, DB/Migration, API, UI, RBAC, States, Browser, Security, Observability and Release through the frozen case set, native runtime evidence, route-backed browser captures, exact-head producer bindings and closure matrix.

## 8. Accountable implementation review

Accountable reviewer identity: **GPT-5.6 Sol — CAP-BIO Technical Review**  
Review date: **2026-08-23**  
Pre-sign exact implementation SHA: `067b7f20745e514a181daa03663332af440d5838`

### Pre-sign evidence disposition

- P11-T001..P11-T018: PASS on the pre-sign exact implementation SHA.
- P11-T019: PASS — exact-head evidence coherence; run `32649222445`, artifact `9495775565`, digest `sha256:e9245fe0b63e340b082c70faf72f47f1dc9cf7c7ead31d9b7acf0a0d7177f14c`.
- P11-T020: PASS — pre-sign closure / merge-authoritative=false; run `32649222458`, artifact `9495789758`, digest `sha256:4c9385e974911f96cae807094c1bc5912c3c7e6e9ecd7eb1947c0add7330461e`.
- P11 Bio Contract: PASS; run `32649222412`, artifact `9495713990`, digest `sha256:1f29b8d6baa0a92b58319a460d5a2b39ef87fdd871839a4e06c0b7e0cb2a4c41`.
- P11 Real Bio Integration: PASS; run `32649222436`, artifact `9495740566`, digest `sha256:65020a164523888440bd9db3cb849f926b672cd4ea7f7ed25038f0e50fe4b47a`.
- P11 Workspace Bio Browser: PASS; run `32649222479`, artifact `9495771872`, digest `sha256:f72b052b20d3b1cd8c3e965b94ba8306b491a8532ab522ba5021f77604ccb66b`.
- Pre-sign closure bound 19/19 P11 input evidence and 34/34 affected current-head workflows to `067b7f20745e514a181daa03663332af440d5838`; required-workflow `missing=[]`, `pending=[]`, `failed=[]`.
- Revision-specific `P08 Closure`, `P09 Closure` and `P10 Closure` are not reinterpreted on a P11 HEAD. Their authority is inherited transitively/directly through the authoritative signed P10 source below.
- Inherited P10 authority: signed source `7db4fca49ba3fd8e60600ecdf41847c7e2f94776`, closure run `32643830718`, artifact `9494371271`, digest `sha256:6a4bcaed870c6432df40e1fe71cb38dd05a84789d3539ab10dabcbfefe450c50`, `phase=signed`, `merge_authoritative=true`, defects 0/0/0.

The reviewed evidence demonstrates real MySQL/Redis persistence and current child-destination risk authority, native Go platformapi behavior, fail-closed publication/risk transitions, permanent Bio noindex/sitemap exclusion, route-backed owner/viewer Workspace and public Chromium behavior, responsive/mobile accessibility evidence, and clean runtime capture error files. No mock/manual/fixture-only success authority is accepted for P11 Exit.

### Role approvals

- Backend Lead: APPROVED
- Frontend Lead: APPROVED
- QA Lead: APPROVED
- Accessibility Reviewer: APPROVED
- Security Reviewer: APPROVED
- Product/API Reviewer: APPROVED

### Defect and decision ledger

- P0 defects: 0
- P1 defects: 0
- `DECISION REQUIRED`: 0

### Gate and ownership disposition

- G3 P11: PASS — CAP-BIO functional/API/browser subset only.
- G7 P11: PASS — Bio UGC/noindex/sitemap-exclusion subset only.
- `CAP-BIO-OPT-IN-INDEX`: **DEFERRED** — P11 exposes no indexing toggle, persisted indexing authority, opt-in query path, canonical authority or sitemap membership.
- P16 destination-risk provider review/operator adjudication/admin lifecycle remains OPEN and later-owned; P11 consumes only current-repository child-destination safety authority.
- Full/release-wide G7 remains OPEN and later-owned by P18/P19/P20/P22.

This review signs the accountable technical disposition of the pre-sign implementation and evidence. It does not claim that the new signed HEAD is already merge-authoritative.

## 9. Signed-revision rule

This signature changes HEAD. Therefore the signed revision itself must rerun P11-T001..P11-T020 and the complete 34-workflow affected exact-head matrix, while continuing to bind the authoritative P10 signed closure.

The signed HEAD is authoritative only if the signed revision itself must rerun and then returns `status=PASS`, `phase=signed`, `merge_authoritative=true`, 19/19 input evidence, 34/34 required workflows, and the signed defect ledger remains P0=0, P1=0, `DECISION REQUIRED`=0.

`CAP-BIO-OPT-IN-INDEX` remains DEFERRED after P11 closure. P16 destination-risk review/admin completion and full/release-wide G7 with P18/P19/P20/P22 remain later-owned.

Until that same-revision signed closure passes, PR #30 must remain Draft and P11 must not be marked complete or merged. SAME-REVISION CI REQUIRED.
